-
公开(公告)号:EP1220852A1
公开(公告)日:2002-07-10
申请号:EP00969490.2
申请日:2000-10-11
申请人: Novartis AG
发明人: ALBERT, Rainer , EHRHARDT, Claus , HOMMEL, Ulrich , KALLEN, Jörg , MEINGASSNER, Josef, Gottfried , ROCHE, Didier , WATTANASIN, Sompong , WEITZ-SCHMIDT, Gabriele , WELZENBACH, Karl
IPC分类号: C07D401/06 , C07D243/08 , A61K31/4709 , A61K31/551
CPC分类号: C07K5/06139 , A61K38/05 , A61K31/00 , A61K2300/00
摘要: The invention provides novel diazepanes having interesting pharmaceutical properties, particularly in preventing or treating disorders or diseases mediated by LFA-1/ICAM-1, -ICAM-2 or -ICAM-3 interactions.
-
公开(公告)号:EP1154988A1
公开(公告)日:2001-11-21
申请号:EP00916832.9
申请日:2000-02-14
发明人: BAENTELI, Rolf , BAUER, Wilfried , COTTENS, Sylvain , EHRHARDT, Claus , HOMMEL, Ulrich , KALLEN, Jörg , MEINGASSNER, Josef, Gottfried , NUNINGER, François , WEITZ-SCHMIDT, Gabriele
IPC分类号: C07C235/26 , C07C237/18 , C07C235/30 , C07C237/20 , C07D211/76 , C07D265/24 , C07D401/06 , A61K31/4402 , A61K31/45 , A61K31/4545 , A61K31/535 , A61P9/10 , A61P3/06 , A61P29/00 , A61P37/00
CPC分类号: C07C271/12 , C07C235/26 , C07C235/30 , C07C237/18 , C07C2602/28 , C07D211/76 , C07D265/10
摘要: Mevinolin derivatives wherein the lactone ring is modified have interesting pharmaceutical properties, particularly in preventing or treating disorders or diseases mediated by LFA-1/ICAM-1 interactions.
摘要翻译: 其中内酯环被改性的美维诺林衍生物具有令人感兴趣的药物性质,特别是在预防或治疗由LFA-1 / ICAM-1相互作用介导的病症或疾病方面。
-
公开(公告)号:EP1220852B1
公开(公告)日:2006-01-18
申请号:EP00969490.2
申请日:2000-10-11
申请人: Novartis AG , Novartis Pharma GmbH
发明人: ALBERT, Rainer , EHRHARDT, Claus , HOMMEL, Ulrich , KALLEN, Jörg , MEINGASSNER, Josef, Gottfried , ROCHE, Didier , WATTANASIN, Sompong , WEITZ-SCHMIDT, Gabriele , WELZENBACH, Karl
IPC分类号: C07D401/06 , C07D243/08 , A61K31/4709 , A61K31/551
CPC分类号: C07K5/06139 , A61K38/05 , A61K31/00 , A61K2300/00
摘要: The invention provides novel diazepanes having interesting pharmaceutical properties, particularly in preventing or treating disorders or diseases mediated by LFA-1/ICAM-1, -ICAM-2 or -ICAM-3 interactions.
-
4.
公开(公告)号:EP1007033A1
公开(公告)日:2000-06-14
申请号:EP98951317.1
申请日:1998-08-26
发明人: BAUER, Wilfried , COTTENS, Sylvain , GEYL, Dieter , WEITZ-SCHMIDT, Gabriele , KALLEN, Jörg , HOMMEL, Ulrich
IPC分类号: A61K31/365 , A61K31/22 , A61K31/19 , A61K31/44 , C07D309/10 , C07D309/30 , C07D319/06 , C07D213/64
CPC分类号: C07D213/64 , A61K31/00 , A61K31/222 , A61K31/366 , C07C219/24 , C07C235/30 , C07C237/18 , C07C237/22 , C07C2601/08 , C07C2602/28 , C07D207/16 , C07D295/13 , C07D295/145 , C07D295/205 , C07D307/52 , C07D309/10 , C07D309/30 , C07D405/12 , C07D491/10
摘要: The present invention relates to compounds which bind to all or parts of the active binding 'south pole pocket' of the LFA-1 I-domain and their uses as LFA-1 antagonists.
摘要翻译: 美维林化合物,用于治疗或预防自身免疫疾病,炎症,缺血/再灌注损伤和移植排斥反应。 这样的化合物结合LFA-1 I结构域,从而抑制LFA-1 / ICAM-1或LFA-1 / ICAM-3相互作用。
-
公开(公告)号:EP1007033B1
公开(公告)日:2008-04-23
申请号:EP98951317.1
申请日:1998-08-26
申请人: Novartis AG , Novartis Pharma GmbH
发明人: BAUER, Wilfried , COTTENS, Sylvain , GEYL, Dieter , WEITZ-SCHMIDT, Gabriele , KALLEN, Jörg , HOMMEL, Ulrich
IPC分类号: A61K31/365 , A61K31/22 , A61K31/19 , A61K31/44 , C07D309/10 , C07D309/30 , C07D319/06 , C07D213/64
CPC分类号: C07D213/64 , A61K31/00 , A61K31/222 , A61K31/366 , C07C219/24 , C07C235/30 , C07C237/18 , C07C237/22 , C07C2601/08 , C07C2602/28 , C07D207/16 , C07D295/13 , C07D295/145 , C07D295/205 , C07D307/52 , C07D309/10 , C07D309/30 , C07D405/12 , C07D491/10
摘要: The present invention relates to compounds which bind to all or parts of the active binding 'south pole pocket' of the LFA-1 I-domain and their uses as LFA-1 antagonists.
-
公开(公告)号:EP1154988B1
公开(公告)日:2004-08-11
申请号:EP00916832.9
申请日:2000-02-14
申请人: Novartis AG , Novartis Pharma GmbH
发明人: BAENTELI, Rolf , BAUER, Wilfried , COTTENS, Sylvain , EHRHARDT, Claus , HOMMEL, Ulrich , KALLEN, Jörg , MEINGASSNER, Josef, Gottfried , NUNINGER, François , WEITZ-SCHMIDT, Gabriele
IPC分类号: C07C235/26 , C07C237/18 , C07C235/30 , C07C237/20 , C07D211/76 , C07D265/24 , C07D401/06 , A61K31/4402 , A61K31/45 , A61K31/4545 , A61K31/535 , A61P9/10 , A61P3/06 , A61P29/00 , A61P37/00
CPC分类号: C07C271/12 , C07C235/26 , C07C235/30 , C07C237/18 , C07C2602/28 , C07D211/76 , C07D265/10
摘要: Mevinolin derivatives wherein the lactone ring is modified have interesting pharmaceutical properties, particularly in preventing or treating disorders or diseases mediated by LFA-1/ICAM-1 interactions.
-
-
-
-
-